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Abstract
Heterozygous activating variants in platelet-derived growth factor, beta (PDGFRB) are
associated with phenotypes including Kosaki overgrowth syndrome (KOGS),
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Penttinen syndrome and infantile myofibromatosis (IM). Here, we present three new
cases of KOGS, including a patient with a novel de novo variant c.1477A > T p.
(Ser493Cys), and the oldest known individual age 53 years. The KOGS phenotype
includes characteristic facial features, tall stature, scoliosis, hyperelastic thin skin, lipo-
dystrophy, variable intellectual and neurological deterioration, and abnormalities on
brain imaging. Long-term outcome is unknown. Our cases confirm the phenotypic
spectrum includes progressive flexion contractures, camptodactyly, widely spaced
teeth, and constriction rings. We also propose novel occasional features including
craniosynostosis, ocular pterygia, anterior chamber cleavage syndrome, early osteo-
porosis, increased pigmentation, recurrent haematomas, predisposition to cellulitis,
nail dystrophy, carpal tunnel syndrome, recurrent hypoglycaemia in infancy, joint dis-
location, and splenomegaly. Importantly, we report fusiform aneurysm of the basilar
artery in two patients. Complications include thrombosis and stroke in the oldest
reported patient and fatal rupture at the age of 21 in the patient with the novel vari-
ant. We conclude that cerebrovascular complications are part of the phenotypic spec-
trum of KOGS and KOGS-like disorders and suggest vascular imaging is indicated in
these patients.
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1 | INTRODUCTION
PDGFRB (OMIM #173410) encodes platelet-derived growth factor
receptor beta, a tyrosine kinase receptor involved in activation of mul-
tiple signalling pathways including cellular proliferation and survival.1
Activating missense mutations are associated with infantile
myofibromatosis (IM) (OMIM#228550; p.(Pro560Leu), p.(Arg561Cys),
p.(Lys567Glu), and p.(Pro660Thr)),2-5 premature ageing syndrome,
Penttinen type (OMIM#601812; p.(Val665Ala),6 and Kosaki over-
growth syndrome (KOGS) (OMIM#616592; p.(Trp566Arg) and p.
(Pro584Arg).7,8 Novel PDGFRB variants including p.(Asn666His),9 p.
(Arg561_Tyr562delinsHis),10 and p.(Asn666Ser)11 have also been
reported in patients with phenotypes overlapping these disorders. A
schematic representation of the PDGFRB protein with the location of
activating variants is shown in Figure 1. Loss-of-function variants are
associated with idiopathic basal ganglia calcification (IBGC) syndrome
(OMIM#615007; p.(Leu658Pro) and p.(Arg987Trp)).12 Somatic acti-
vating mutations have been identified in tissue from fusiform cerebral
aneurysms p.(Tyr562Cys).13 Somatic rearrangements with a t(5;12)
translocation leading to a ETV6-PDGFRB fusion gene are associated
with myeloproliferative disorder with eosinophilia (OMIM#131440).14
KOGS was first described in 2015 and to date, six patients have
been reported with ages ranging from 3 to 19.7,8,15,16 The phenotype
includes characteristic facial features, postnatal tall stature, long hands
F IGURE 1 Schematic
representation of the PDGFRB
protein with location of
activating mutations associated
with Kosaki overgrowth
syndrome, Pentinnen syndrome,
infantile myofibromatosis, and
other overlapping phenotypes
[Colour figure can be viewed at
wileyonlinelibrary.com]
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and feet, variable intellectual disability and neurological deterioration,
scoliosis, hyperelastic thin and fragile skin, lipodystrophy, abnormali-
ties on brain magnetic resonance imaging (MRI) including white matter
lesions, ventricular enlargement/hydrocephalus and arachnoid cysts,
and myofibromas in some individuals7,8,15-17. Long-term outcome has
not previously been reported and is of great interest given the appar-
ently progressive course of this disorder.
Here, we report three new individuals with KOGS including the
oldest patient at the age of 53 and expand the phenotype of this dis-
order. We describe a young adult with a novel variant in PDGFRB
c.1477A > T p.(Ser493Cys), adding to our knowledge of the
genotype-phenotype correlations in PDGFRB-related disorders. Impor-
tantly, we report cerebrovascular complications in both adults,
highlighting the morbidity and mortality associated with this group of
disorders.
2 | MATERIALS AND METHODS
Patients have been collected through a collaboration call launched
within the European Reference Network ITHACA. Clinical information
has been gathered. All variant descriptions in this article and in the
cited literature refer to (NM_002609.3).
Exome capture and sequencing was performed at the Centre
National de Génotypage (CNG) in patient 1 from 1 μg of genomic
DNA per individual using the SureSelect Human All Exon v5_51Mb
kit (Agilent, Santa Clara, California). The resulting libraries were
sequenced on a HiSeq 2000 (Illumina, San Diego, California)
according to the manufacturer's recommendations for paired-end
76 bp reads. Raw data were processed as previously described
(Thevenon, 2016).18 A recurrent PDGFRB chr5:g.149505064G > C,
c.1751C > G, p.(Pro584Arg) variant was reported as pathogenic in
ClinVar.
Patient 2 underwent next generation sequencing (NGS) on a
custom-targeted panel of 44 overgrowth genes as part of the
Phenotyping of Overgrowth Disorders (POD) research study (CPMS
19361) in the West Midlands Regional Genetics Laboratory (WMRGL)
in the United Kingdom. The 2 μg of DNA extracted from lymphocytes
underwent SureSelect QXT target enrichment (Agilent) and libraries
were sequenced on the MiSeq (Ilumina) according to manufacturer's
protocols. SureCall (Agilent) software was used for bioinformatic anal-
ysis. A pathogenic variant c.1751C > G p.(Pro584Arg) was identified
in PDGFRB. Bi-directional Sanger sequencing on the ABI3730 of exon
12 of the PDGFRB gene confirmed the heterozygous presence of
c.1751C > G p.(Pro584Arg) variant. Sanger sequencing of parental
samples did not identify the variant.
Patient 3, together with parents, was recruited to the 100 000
Genomes Project. DNA was extracted from lymphocytes at the
WMRGL and sent to Illumina for Whole Genome Sequencing.
Sequencing data were passed through Genomics England's bioinfor-
matics pipeline for alignment, annotation and variant calling. Based on
the Human Phenotype Ontology terms entered for this patient, the
following gene panels were applied: Ehlers Danlos syndromes v1.43,
Inherited bleeding disorders v1.153, Intellectual disability v2.800
(panelapp.genomicsengland.co.uk). The c.1477A > T p.(Ser493Cys)
variant, with de novo inheritance, was identified in the PDGFRB gene
in the heterozygous state. Results were analysed by the WMRGL and
discussed at a multidisciplinary team meeting. This variant was classi-
fied as likely pathogenic according to ACMG and ACGS variant inter-
pretation guidelines19,20 with the following lines of evidence: in silico
tools predict the variant is damaging, the variant is not present in
gnomAD, it is a de novo variant with a specific phenotype, and mis-
sense variants are constrained within this region of PDGFRB.
3 | RESULTS
3.1 | Patient 1
The patient (Figures 2 and 3) was a 53-year-old of French origin ini-
tially published in 1974 by Stoll et al.21 He was born after an unevent-
ful pregnancy to healthy unrelated parents. His four older brothers
were in good health. No particular events were noted during the neo-
natal period and the first year of life. At the age of 15 months dolicho-
cephaly, tall stature, hyperelasticity and skin hyperpigmentation were
noted. A right corneal dystrophy was diagnosed age 5.5 years.
He was referred to a genetic clinic at the age of 8. His height was
143 cm (+ 4 standard deviations [SD]) with an arm span of 142 cm
and weight 29 kg (+2.4 SD). He had progressive dysmorphic facial fea-
tures including hyperostosis of metopic and sagittal sutures that led
to suspicion of craniosynostosis, wide spaced eyes, wide nasal base
and bridge, long philtrum, micrognathia, thin and fragile gums, and
high narrow palate. The skin was atrophic, hyperelastic and hyper-
pigmented, with hypertrophic and dystrophic scars. The joints were
stiff, especially the knees and the ankles. A progressive semi-flexed
position of the fingers, bilateral clinodactyly of the fifth fingers, pes
cavus and claw toes were noted. Total intellectual quotient (IQ) was
measured at 105. Global hypotonia was noted. Skeletal survey rev-
ealed global demineralization, enlarged phalanges, and bone age
advanced by 3 years. A skin biopsy showed atrophic epidermal and
dermal layers, increased epidermal melanic pigmentation, and
increased dermal elastic fibres. The initial differential diagnoses were
Shprintzen-Goldberg syndrome (SGS) or atypical Ehlers Danlos
syndrome.
Pterygia of the right eye at the age of 10 and the left eye at the
age of 32 were treated with keratoplasty, but recurrence in both eyes
resulted in visual impairment. Early osteoporosis was diagnosed at the
age of 37, but the presence of plantar calcifications ruled out treat-
ment with bisphosphonates. Scoliosis was rapidly progressive and not
amenable to surgical intervention. At the age of 53, he presented with
an ischaemic stroke caused by a basilar artery aneurysm thrombosis.
MRI investigations discovered generalised dolichoectasia of the cere-
bral arteries, and arachnoidian cysts of the temporal lobes,
frontoparietal areas and posterior fossa associated with a Dandy-
Walker malformation (Figure 2). Heart and vascular ultrasounds found
normal aortic diameters and no other vessel ectasia. AngioMRI
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revealed a sinuous thoracic aorta. Long-term treatment with low-dose
aspirin was initiated. Sequencing of the SKI gene was negative.
Exome sequencing revealed a recurrent PDGFRB chr5:
g.149505064G > C, c.1751C > G, p.(Pro584Arg) variant reported as
pathogenic in ClinVar. Clinical re-evaluation showed evolving physical
features but no cognitive decline. General examination revealed
marfanoid habitus with tall stature (188 cm) despite severe scoliosis,
dolichostenomelia, minor pectus carinatum, and stiff joints with genu
valgum and amyotrophy. Macropenis was noted with enlarged glans.
Facial features included marked supraorbital ridges, broad nasal tip
with large bridge and base, wide spaced eyes, ptosis, mandibular
hypoplasia, slightly low set ears, smooth philtrum, thin upper-lip and
square chin. Hairs were fine with generalised hypotrichosis. Dermato-
logic features were particularly marked, with diffuse erythrosis,
absence of subcutaneous fat, atrophic and fragile skin with general-
ised abnormal appearance of blood vessels and hypertrophic, retrac-
tile and sometimes calcified scars of the extremities, secondary to
minor injuries. There was no cutis laxa, skin hyperelasticity or dental
anomaly. There was camptodactyly of 2-5th fingers, Ainhum circum-
ferential constriction of the second and third toe of the left foot,
severely dystrophic nails and pterygia of two toenails. Re-evaluation
of cerebral MRIs and CT scans did not reveal cerebral calcification.
Compassionate use of tyrosine kinase inhibitors was discussed but
declined by the patient.
3.2 | Patient 2
Patient 2 (Figure 4) was born at 37 weeks gestation weighing 3.7 kg
(+1.9 SD) following induction of labour for prolonged rupture of the
membranes and oligohydramnios. His parents were unrelated white
British and his younger sibling and two elder maternal half siblings
were healthy. At 48 hours of age, he had a bilateral orchidopexy for
suspected testicular torsion and was noted to have cryptorchidism.
F IGURE 2 Clinical features of patient 1. A, During childhood. B-E, Age 53 years. Facial features, A and B, include supraorbital ridge, deep-set
eyes, ptosis, hypertelorism, wide nasal bridge and base, mandibular hypoplasia, thin lips, smooth philtrum and square chin. Skin is atrophic with
absence of subcutaneous fat, diffuse erythrosis, and abnormal blood vessels, C and D. Marfanoid habitus with tall stature, severe scoliosis, stiff
joints, amyotrophia, and large penis, D-F. Hypertrophic, retractile and sometimes calcified scars, camptodactyly of 2-5th fingers, severe nail
dystrophia, and Ainhum circumferential constriction of the second and third toe of the left foot, G-I [Colour figure can be viewed at
wileyonlinelibrary.com]
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Multiple suture craniosynostosis (sagittal, coronal, and metopic)
was diagnosed by 14 months of age. Bilateral periventricular cystic
foci were identified on MRI brain scan. At six years of age, he devel-
oped obstructive ventriculomegaly with tonsillar descent and required
insertion of a ventriculo-peritoneal (VP) shunt. Subsequent visual
impairment was attributed to the period of raised intracranial pressure
and to enlargement of mid brain cysts. Visual acuities were perception
of light only in the right eye and 0.6 at 10 cm in the left eye (Kay Pic-
ture Test Linear Crowded Book). He also had conductive hearing loss
due to glue ear and required hearing aids. Primary dentition was lost
prematurely at the age of three years. He developed contractures of
the digits of both hands and equinovarus of the feet and ankles
requiring orthotic treatment with boots. Hand and foot X-rays
showed widening of the metacarpals, metatarsals, and phalanges.
Early developmental milestones were normal, including walking at
the age of 14 months and an Ages and Stages Questionnaire (ASQ)
developmental assessment at the age of four identified no develop-
mental concerns. He was moved from mainstream education to spe-
cial education at the age of six primarily due to visual impairment.
Hearing impairment, flexion contractures of the fingers, and frequent
hospital admissions with recurrent VP shunt blockages were also con-
tributing factors.
On examination in the genetics clinic at the age of six, he had a
tanned appearance with no history of sun exposure and out of
keeping compared to other family members and ethnic background.
Other dermatological features included hyperelastic soft thin skin,
lax skin on the palms, pigmented lesions on the thighs, pectus
excavatum, reduced extension at the elbow, broad hands, progres-
sive flexion contractures of the fingers and toes, and widely spaced
teeth. Dysmorphic facial features consisted of brachycephaly, slop-
ing forehead, prominent supraorbital ridges, widely spaced eyes,
proptosis, downslanting palpebral fissures, wide nasal bridge, wide
nasal base, wide nasal tip, malar flattening, midface retrusion,
smooth philtrum, thin vermilion of the upper lip, everted vermilion
of the lower lip, and prominent ears with forward facing and
uplifted earlobes (Figure 3). At the age of six, his height was
132.5 cm (+2.8 SD), head circumference 51.0 cm (−1.5 SD) and
weight 27.8 kg (+1.7 SD).
Clinical array-comparative genomic hybridisation (aCGH) and cra-
niosynostosis screen (sequencing of FGFR1 exon 7, FGFR3 exons IIIa
and IIIc, FGFR3 exons 7 and 10, TWIST exon 1, FGFR2 exons
3,5,11,14,15,16, 17 and 18 and MLPA of TWIST1, RUNX2, ALX1,
ALX3, ALX4, MSX2, and EFNB1) did not identify any probably patho-
genic variants. A de novo pathogenic variant c.1751C > G, p.
(Pro584Arg) was identified in PDGFRB on an NGS panel of over-
growth genes.
Subsequent echocardiogram at the age of seven was normal. Fur-
ther vascular investigations are planned.
F IGURE 3 Imaging of patient
1. A, Sagittal view of a
T1-weighted cerebral MRI
showing a large posterior fossa
cyst in continuity with the fourth
ventricle associated with an
elevated tent and diffuse
hypoplasia of the cerebellum
(Dandy-Walker syndrome). B-F,
Axial views of a Time Of Flight
(ToF)-weighted cerebral MRI, B,
C, D, Diffuse dolichoectasia of
internal carotid and vertebral
arteries. E, Thrombosis of
fusiform aneurysm of the basilar
artery. F, Bilateral fetal posterior
cerebral arteries. G-H, Axial views
of a cerebral computerised
tomography (CT) scan revealing
the Dandy Walker malformation,
bilateral subarachnoid cysts of
the anterior temporal lobes, and
thrombosis of the fusiform
aneurysm of the basilar artery. I,
Axial view of a T2 Fluid
Attenuated Inversion Recovery
(FLAIR) cerebral MRI showing
mild merging punctiform
hypersignal of the white matter
linked to a microangiopathy and
bilateral asymmetrically
pneumatized frontal sinus
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Bilateral carpal tunnel release was performed for severe median
nerve compression at the age of eight.
3.3 | Patient 3
Patient 3 (Figure 5) was born to unrelated healthy parents and had
two healthy elder sisters. His mother had hypertension from 34 weeks
of pregnancy and labour was induced at term. Despite a normal birth
weight of 3.26 kg, he appeared extremely thin with wrinkled skin. He
also had extremely pale hair and irides and diastasis recti.
He had recurrent hypoglycaemic episodes between the ages of
five months and three years. Extensive metabolic investigations were
unremarkable and he was diagnosed with ketotic hypoglycaemia that
resolved with age. Early developmental milestones were normal.
At the age of 10, a yellow ring around the iris was noted. An oph-
thalmology review identified a minor variant of a Rieger-like anterior
chamber cleavage syndrome, with significant thickening of the periph-
eral millimetre of the iris, prominence of corneal nerves bilaterally and
prominent Schwalbe's lines on the right. Vision was normal.
He had recurrent haematomas and cellulitis of the lower limbs,
and surgical intervention was technically difficult because of abnormal
F IGURE 4 Clinical features and imaging of patient 2. Features of the face and cranium, A-D, brachycephaly, sloping forehead, prominent
supraorbital ridge, wide spaced eyes, proptosis, downslanting palpebral fissures, wide nasal bridge, wide nasal base, wide nasal tip, malar
flattening, midface retrusion, smooth philtrum, thin vermilion of the upper lip, everted vermilion of the lower lip, protruding ears with forward
facing and uplifted earlobes, widely spaced teeth and class III malocclusion resulting from midface retrusion (J). Tanned appearance with thin
hyperelastic skin and wrinkled palms, B,D,F. Tall body habitus with pectus excavatum and reduced extension of the elbows, B,D. Progressive
flexion contractures of the fingers and short wide thumbs, E,F. Broad feet (K). Hand and foot x-rays age three, G, and five, H: Widening of
metacarpals and phalanges with a degree of carpal crowding and some widening of the metatarsals and phalanges; progression of contractures. L:
CT head age 18 months with almost complete fusion of the sagittal, coronal and metopic sutures. M and N: MRI head age three showing
generalised parenchymal volume loss, bilateral posterior periventricular T2 high and flair high signal with focal areas of low signal in keeping with
cystic changes, right cerebral peduncle T2 high signal and Wallerian degeneration with severe cystic gliosis, and small foci of flair hyperintensity in
the bilateral centrum ovale suggesting acute ischaemic foci. O and P: MRI head age five showing foci in the right midbrain occluding the third
ventricle and cerebral aqueduct causing increase in size of the bilateral lateral ventricles and third ventricle, mild mass-effect with midline shift,
inferior descent of the brainstem and cerebellar tonsils and possible compression of the optic nerve/chiasm. Q: CT head age five showing copper
beaten skull related to chronic raised intracranial pressure [Colour figure can be viewed at wileyonlinelibrary.com]
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blood vessels. He had pain in his joints and the soles of the feet from
early childhood.
On review in the genetics clinic age of 11, his height was
143.9 cm (50th centile), weight 42.7 kg (+1.1 SD) and OFC 56.5 cm
(+1.0 SD). He had low body fat and a muscular build. The right leg and
foot were smaller than the left due to a fractured tibia and treatment
with plaster at the age of four with subsequent muscle wasting. He
had a tanned appearance. The skin was soft and lax with wrinkled
palms and soles, mobile prominent veins and varicosities on distal
upper and lower limbs, easy bruising, numerous non-atrophic scars,
and little body hair. He had hypermobility of small joints, left knee,
and spine; and divarification of the rectus muscles. Dentition was at
least two years advanced with prominent gums and wide spaced
teeth. Hands and feet were large with broad digits. Facial features of
prominent supraorbital ridges, wide spaced eyes, broad nose and
broad nasal bridge were noted. A pulsatile lump was present on the
occiput and confirmed to be a vascular malformation when surgically
removed at the age of 12. Shoulder dislocation occurred at the age of
15. He attended mainstream school with some learning support but
did not require a statement of special educational needs and went on
to attend university. At the age of 20, his height was 185.4 cm (+1.2
SD) and weight was 97.4 kg (+1.9 SD) and splenomegaly was noted.
Cranial MRI scan showed hypoplasia of both superior and inferior
cerebellar vermis and prominent posterior fossa subarachnoid spaces
with bilateral subcortical high signal areas. Other investigations includ-
ing bone age, metabolic studies (urinary GAGs and AA, oligosaccha-
rides, sialic acid, MCAD screen), platelets, bleeding time and clotting
screen, chromosomal analysis, CGH array, FLNA, fibroblast analysis
for collagen type I, III and V, and molecular analysis of COL3A1 and
COL5A1 were unremarkable. At the age of 20, skeletal survey
reported significant prominence of the frontal bone, which was
unaerated and slightly increased bone density with undermodelling of
F IGURE 5 Clinical features and imaging of patient 3. Facial features: prominent supraorbital ridges, broad nose and broad nasal bridge age
9, A, age 11, D,I, and age 20, G,H. Yellow ring around the iris, F. Reduced subcutaneous fat, B. Large hands with broad digits, C, and thin
hyperelastic skin with wrinkled palms and soles, C,I. J,K: Intracranial CT angiogram showing prominent frontal bone and thrombosis of a large
fusiform aneurysm of the basilar artery, the majority of which is thrombosed. L-O, MRA head showing large fusiform aneurysm of the basilar
artery indenting the brain stem and including an area of thrombosis, multiple foci of signal change in the supratentorial white matter in keeping
with chronic small vessel ischaemia, and multiple areas of presumed dural ectasia with thinning of the skull vault and skull base [Colour figure can
be viewed at wileyonlinelibrary.com]
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the distal femur and proximal tibia with possible mild elongation of
the metacarpals and metatarsals. EMG showed no evidence of myoto-
nia and nerve conduction studies showed normal motor and sensory
conduction in the upper and lower limbs.
A 3 cm soft mobile lump that developed on the left shin at the
age of 14 was reported as a benign angiofibromatous lesion with
unusual histology.
At the age of 21, he had a fatal stroke. CT and MRI images
showed a basilar artery aneurysm thrombosis with subsequent dis-
section of the aneurysm and subarachnoid haemorrhage. Multiple foci
of signal change in the supratentorial white matter in keeping with
chronic small vessel ischaemia were also seen. Post-mortem examina-
tion confirmed a ruptured fusiform aneurysm of the basilar artery
measuring up to 2.5 cm in maximum diameter. The vertebral arteries
were normal and the aorta was unremarkable. The coronary arteries
showed moderate calcified atheroma.
This patient was posthumously recruited to the 100 000
Genomes Project. Whole genome sequencing identified a previously
unreported de novo variant c.1477A > T p.(Ser493Cys) in PDGFRB.
4 | DISCUSSION
KOGS is an ultra-rare disorder largely underdiagnosed with only six
cases reported worldwide. Although a recognisable phenotype, the
majority of cases have been diagnosed following a genotype-first
approach, due to lack of knowledge of the disorder. A number of key
features have been identified but each reported case has expanded
the spectrum, leading to a heterogeneous phenotype with constant,
occasional and rare features (Figure 6). Characteristic facial features
include wide spaced eyes, downslanting palpebral fissures, wide nasal
bridge and nasal base, broad nasal tip, pointed chin, prominent
supraorbital ridges, underdeveloped malae, cupid bow shaped and thin
upper lip, proptosis and smooth philtrum.15 Tall stature, MRI abnor-
malities including white matter lesions, arachnoid cysts, Dandy-
Walker malformation and hydrocephalus, abnormal cranial shape, thin
fragile hyperelastic skin, scoliosis, premature ageing, lipodystrophy,
sparse hair, hypotonia in infancy, delayed speech and language, intel-
lectual disability, neurological deterioration, and myofibroma are also
recognised features.15,16 Our cases confirm that several features pre-
viously reported in only a single individual with KOGS, including
camptodactyly, progressive joint contractures, widely spaced teeth,
and constriction rings7,8,15 are part of the phenotypic spectrum. We
also report novel features including craniosynostosis, ocular pterygia,
anterior chamber cleavage syndrome, early osteoporosis, enlarged
penis, diffuse erythrosis, increased pigmentation, recurrent
haematomas, predisposition to cellulitis, nail dystrophy, carpal tunnel
syndrome, recurrent hypoglycaemia in infancy, muscular build, joint
dislocation, and splenomegaly (Table 1). In one of our patients visual
impairment resulted from KOGS-related obstructive ventriculomegaly
and mid brain cysts.
The identification of the oldest patient provides valuable informa-
tion about the natural history of KOGS in later life. This individual has
normal intellectual functioning at the age of 53, demonstrating the
progressive neurological deterioration and intellectual disability in
other reported individuals7,8 is not universal. Cerebral angioMRI rev-
ealed both large vessel and small vessel anomalies with enlarged and
dysplastic cervical and intracranial arteries (internal carotids, vertebral
arteries, basilar artery) and a fusiform aneurysm of the basilar artery,
and punctiform hypersignal of the subcortical white matter related to
microvascular angiopathy too extensive for age. A vascular phenotype
was also unfortunately diagnosed post-mortem in patient 3, following
investigation of sudden death at the age of 21 from a ruptured fusi-
form aneurysm of the basilar artery.
F IGURE 6 Frequency of general
clinical features, A, and facial
features, B, in published patients
with KOGS [Colour figure can be
viewed at wileyonlinelibrary.com]
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A vascular phenotype has been previously reported in KOGS,16 in
a patient with saccular aneurysms in both coronary artery systems
and mild tortuosity of the cervical vertebral arteries. This individual
died suddenly at the age of 19 without post-mortem examination.
The vascular findings in our cases confirm that vascular features are
part of the phenotypic spectrum of KOGS and are associated with
both known KOGS-genotypes c.1696 T > C p.(Trp566Arg) and
c.1696 T > C p.(Trp566Arg) and also with the novel PDGFRB variant
c.1477A > T p.(Ser493Cys). Echocardiograms have been performed
on three younger individuals with molecularly confirmed KOGS,
including our patient 2 at the age of six, and no other vascular anoma-
lies have been identified. However, several features of KOGS such as
the prematurely aged appearance are progressive, and it is probably
that vascular complications may develop with age. Given the morbid-
ity and mortality associated with vascular phenotypes, we suggest
that clinicians consider baseline vascular screening with echocardio-
gram, cerebral MRI and angioMRI for individuals with KOGS at diag-
nosis and again in adult life.
There are numerous other lines of evidence suggesting that vas-
cular complications may be associated with the wider PDGFRB-
spectrum disorders. A patient with a clinical diagnosis of Pentinnen
syndrome and major dilatation of the left coronary system on echo-
cardiogram age seven and a haemorrhagic stroke secondary to aneu-
rysm of the basilar artery age nine have been reported.22 She had
many of the shared clinical features of a PDGFRB-related disorder—
thin fragile skin, sparse hair, kyphoscoliosis, progressive joint contrac-
tures, tall stature (height > 3SD), ocular pterygia, MRI findings of
hydrocephalus, arachnoid cysts, white matter lesions and multiple
craniosynostosis—in addition to the characteristic progressive acro-
osteolysis, nodular scarring and facial features of Penttinen syndrome.
A molecular diagnosis in this case would provide further insight into
the genotype-phenotype correlations between specific PDGFRB muta-
tions and vascular complications. In addition, Karasozen et al reported
the case of a 23-year-old man with progressive intracranial aneurysms
and ipsilateral cutaneous phenotype with a somatic missense patho-
genic variant p.(Tyr562Cys) within the PDGFRB gene predicted to
generate a stream of hyperphosphorylation13 . Upregulation of
PDGFRB expression has also been showed in aortic wall tissue from
patients with thoracic aortic dissection.23 All these elements consti-
tute strong arguments for activating mutations of the PDGFRB gene
leading to global vascular pathology.
The high morbidity and mortality associated with vascular compli-
cations and the progressive natural history of KOGS make the possi-
bility of therapeutic intervention an important consideration. To date,
two individuals with other PDGFRB-related disorders have been
treated with tyrosine kinase inhibitors. The patient reported by Pond
et al was treated with imatinib with clinical improvement in contrac-
tures of the hands and decrease in coarseness of the facial features.9
Mudry et al reported a patient with a germline heterozygous
c.1681C > A p.(Arg561Cys) missense mutation causing generalised
infantile myofibromatosis. After failure of multiple lines of chemother-
apy, the multiple tumours finally responded to a combination of sun-
itinib and vinblastine.24 It has been established that the KOGS-
specific pathogenic variants in PDGFRB are activating mutations that
activate the PI3K-AKT pathway16 and are responsive to imatinib25
suggesting that individuals with KOGS might also be candidates for
treatment with tyrosine kinase inhibitors.
In this report, we also extend the genotype-phenotype correla-
tions associated with PDGFRB related disorders. Our patient 3 with a
novel PDGFRB variant c.1477A > T p.(Ser493Cys) shares many fea-
tures with the KOGS phenotype including typical facial features,
hyperelastic thin skin, lipodystrophy and MRI brain anomalies. His
tanned appearance and wrinkled palms are strikingly similar to those
of patient 2. His growth (on the 50th centile) is not typical of KOGS
but given the small number of reported patients, it is possible that tall
stature is not universal in this condition. Variability in height exists in
other PDGFRB-spectrum disorders. For example, two of the five
reported individuals with molecularly confirmed Penttinen syndrome
have overgrowth.6,22,26 Patient 3 also has novel features including
recurrent hypoglycaemia in infancy, minor anterior chamber cleavage
syndrome, recurrent haematomas and cellulitis of the lower limbs, a
muscular build, joint dislocation and splenomegaly. Further observa-
tions of patients with this novel variant will inform the medical com-
munity if these features are specific to this variant or not.
Interestingly, this novel variant is located in the transmembrane
domain of PDGFRB, whereas the other known KOGS variants are in
the juxtamembrane domain of the protein.
Recently, individuals with novel mutations in PDGFRB not previ-
ously associated with KOGS, Penttinen or IM have been reported.
Two different variants at the same amino acid in the tyrosine kinase
hinge region of PDGFRB, c.1997A>G p.(Asn666Ser)11 and
c.1996A > C p.(Asn666His),9 are both associated with Penttinen-like
phenotypes, but the two patients reported by Bredrup et al have a
more severe phenotype. The pterygium described in our patient
1 was also seen in Bredrup's patient 2, and the carpal tunnel syn-
drome in our patient 2 also developed in the Pond patient. The case
reported by Guimier et al c.1682_1684del p.(Arg561_Tyr562-
delinsHis),10 a somatic loss-of-function variant in the juxtamembrane
region, has a phenotype overlapping KOGS and Penttinen but also
has bilateral periventricular and basal ganglia calcifications as seen in
IBGC 4 and multifocal myofibromatosis as seen in IM. This patient
also has the wrinkled palms and soles seen in our patients 2 and
3. These novel variants, together with our variant, raise the question
of the delineation of the phenotypes secondary to gain-of-function
PDGFRB variants. The term of PDGFRB gene activation-related disor-
ders might be more appropriate.
In conclusion, we describe here the long-term outcome in the oldest
reported individual with KOGS, report a patient with a novel PDGFRB
variant and a KOGS-like phenotype, and highlight the vascular risk in
KOGS. We suggest that vascular investigations are indicated in individ-
uals with KOGS and KOGS-like disorders. Therapeutic options are of
great interest in the future clinical management of these patients.
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